• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘢痕疙瘩治疗进展:一种针对耳部瘢痕疙瘩的新型多模式方法

Advancing Keloid Treatment: A Novel Multimodal Approach to Ear Keloids.

作者信息

Jones Michael E, McLane Jennifer, Adenegan Rachael, Lee JoAnne, Ganzer Christine A

机构信息

*Lexington Plastic Surgeons, New York, New York; †Hunter-Bellevue School of Nursing, Hunter College, New York, New York.

出版信息

Dermatol Surg. 2017 Sep;43(9):1164-1169. doi: 10.1097/DSS.0000000000001145.

DOI:10.1097/DSS.0000000000001145
PMID:28375976
Abstract

BACKGROUND/OBJECTIVE: Management of keloids of the pinna, in particular, those located in the helix and antihelix and lobule that occur as complications of ear piercing.

MATERIALS AND METHODS

Retrospective analysis of 49 patients treated with extralesional surgical excision of keloids localized to the ear followed by the application of autologous platelet-rich plasma (PRP) to wound site and postoperative in-office superficial radiation therapy (SRT). Radiation protocol consisted of 1 to 3 fractions, with cumulative dosage ranging from 1,300 to 1,800 cGy. Average follow-up was 24 months to assess for evidence of recurrence and adverse side effects.

RESULTS

Fifty ear keloids were treated with this method, age from 15 to 66 (mean = 32, SD = 16) of which 14 were male and 35 female. Almost 30% (n = 14) of patients acknowledged the source of injury that led to the development of the keloid was ear piercing. Treatment protocol achieved a 94% success rate with 3 patients who reported recurrence.

CONCLUSION

Surgical excision combined with intraoperative PRP, adjuvant postoperative in-office SRT achieved a 94% nonrecurrence rate on follow-up over a 2-year period. Outcomes provide preliminary, albeit, strong evidence to support this multimodal method as a viable alternative in the management of keloids localized to the ear.

摘要

背景/目的:耳廓瘢痕疙瘩的治疗,尤其是发生在耳轮、对耳轮和耳垂部位,作为穿耳洞并发症出现的瘢痕疙瘩。

材料与方法

对49例患者进行回顾性分析,这些患者接受了耳廓瘢痕疙瘩的病灶外手术切除,随后在伤口部位应用自体富血小板血浆(PRP)并进行术后门诊浅表放射治疗(SRT)。放射治疗方案包括1至3次分割,累积剂量范围为1300至1800 cGy。平均随访24个月以评估复发证据和不良副作用。

结果

采用该方法治疗了50个耳部瘢痕疙瘩,年龄在15至66岁之间(平均=32,标准差=16),其中男性14例,女性35例。近30%(n = 14)的患者承认导致瘢痕疙瘩形成的损伤来源是穿耳洞。治疗方案的成功率为94%,有3例患者报告复发。

结论

手术切除联合术中PRP及术后辅助门诊SRT在2年随访期内实现了94%的无复发率。结果提供了初步的、尽管有力的证据,支持这种多模式方法作为耳部局限性瘢痕疙瘩管理的可行替代方案。

相似文献

1
Advancing Keloid Treatment: A Novel Multimodal Approach to Ear Keloids.瘢痕疙瘩治疗进展:一种针对耳部瘢痕疙瘩的新型多模式方法
Dermatol Surg. 2017 Sep;43(9):1164-1169. doi: 10.1097/DSS.0000000000001145.
2
Treatment of earlobe keloids by extralesional excision combined with preoperative and postoperative "sandwich" radiotherapy.手术切除联合术前和术后“三明治”放疗治疗耳垂瘢痕疙瘩。
Plast Reconstr Surg. 2010 Jan;125(1):135-141. doi: 10.1097/PRS.0b013e3181c2a46e.
3
A retrospective analysis of surgical resection of large ear keloids.大耳瘢痕疙瘩手术切除的回顾性分析
Australas J Dermatol. 2019 Feb;60(1):29-32. doi: 10.1111/ajd.12872. Epub 2018 Jul 1.
4
Analysis of the surgical treatments of 63 keloids on the cartilaginous part of the auricle: effectiveness of the core excision method.63例耳廓软骨部瘢痕疙瘩的手术治疗分析:核心切除法的有效性
Plast Reconstr Surg. 2015 Mar;135(3):868-875. doi: 10.1097/PRS.0000000000000962.
5
Keloid Management: A Retrospective Case Review on a New Approach Using Surgical Excision, Platelet-Rich Plasma, and In-office Superficial Photon X-ray Radiation Therapy.瘢痕疙瘩的治疗:关于采用手术切除、富血小板血浆和门诊浅表光子X线放射治疗的新方法的回顾性病例分析
Adv Skin Wound Care. 2016 Jul;29(7):303-7. doi: 10.1097/01.ASW.0000482993.64811.74.
6
Retrospective study of immediate postoperative electron radiotherapy for therapy-resistant earlobe keloids.治疗抵抗性耳垂瘢痕疙瘩的即刻术后电子放疗的回顾性研究。
Arch Dermatol Res. 2019 Aug;311(6):469-475. doi: 10.1007/s00403-019-01922-z. Epub 2019 Apr 30.
7
Triple treatment in ear keloids: Comparison of post-excisional intralesional steroid and platelet-rich plasma treatment.耳部瘢痕疙瘩的三联治疗:切除后皮损内类固醇与富血小板血浆治疗的比较。
Am J Otolaryngol. 2021 May-Jun;42(3):102935. doi: 10.1016/j.amjoto.2021.102935. Epub 2021 Jan 22.
8
A primary protocol for the management of ear keloids: results of excision combined with intraoperative and postoperative steroid injections.耳部瘢痕疙瘩管理的主要方案:切除联合术中及术后类固醇注射的结果
Plast Reconstr Surg. 2007 Oct;120(5):1395-1400. doi: 10.1097/01.prs.0000279373.25099.2a.
9
Treatment of auricular keloids by triple combination therapy: Surgical excision, platelet-rich plasma, and cryosurgery.三联联合疗法治疗耳廓瘢痕疙瘩:手术切除、富血小板血浆和冷冻手术。
J Cosmet Dermatol. 2018 Jun;17(3):502-510. doi: 10.1111/jocd.12552. Epub 2018 Apr 16.
10
Earlobe keloids: emerging cosmetic complication of ear-piercing.耳垂瘢痕疙瘩:穿耳洞新出现的美容并发症。
Nig Q J Hosp Med. 2010 Apr-Jun;20(2):97-100. doi: 10.4314/nqjhm.v20i2.58046.

引用本文的文献

1
Comprehensive analysis of keloid super-enhancer networks reveals FOXP1-mediated anti-senescence mechanisms in fibrosis.瘢痕疙瘩超级增强子网络的综合分析揭示了FOXP1介导的纤维化抗衰老机制。
Cell Mol Biol Lett. 2025 Jul 23;30(1):88. doi: 10.1186/s11658-025-00763-1.
2
An Effective Auricular Keloids Management Method: Excision of the Original Lesion and Postoperative Corticosteroids.一种有效的耳部瘢痕疙瘩治疗方法:切除原发病灶及术后使用皮质类固醇激素
Aesthetic Plast Surg. 2025 Jun 5. doi: 10.1007/s00266-025-04925-6.
3
Intralesional injection of vitamin D3, platelet rich plasma versus their combination in treatment of keloid: a clinical, radiological and immunohistochemical study.
病灶内注射维生素D3、富血小板血浆及其联合治疗瘢痕疙瘩的临床、放射学及免疫组织化学研究
Arch Dermatol Res. 2025 May 20;317(1):773. doi: 10.1007/s00403-025-04244-5.
4
CEMIP induces TGF-β/Smad signaling to promote keloid development by binding to SPARC.CEMIP 通过结合 SPARC 诱导 TGF-β/Smad 信号通路促进瘢痕疙瘩的发展。
Clinics (Sao Paulo). 2024 Oct 29;79:100523. doi: 10.1016/j.clinsp.2024.100523. eCollection 2024.
5
Future Directions About Keloid Scars Based on Pathogenesis and Therapies.基于发病机制和治疗方法的瘢痕疙瘩未来研究方向
Clin Cosmet Investig Dermatol. 2024 Oct 25;17:2391-2408. doi: 10.2147/CCID.S470650. eCollection 2024.
6
The History and Current Status of Platelet-Rich Plasma Therapy in Dermatology.皮肤科富血小板血浆疗法的历史与现状
Cureus. 2024 Aug 31;16(8):e68306. doi: 10.7759/cureus.68306. eCollection 2024 Aug.
7
Clinical evaluation of intralesional umbilical cord-derived mesenchymal stem cells, conditioned medium and triamcinolone acetonide injection for keloid treatment: A pilot study.病灶内注射脐带间充质干细胞、条件培养基及曲安奈德治疗瘢痕疙瘩的临床评估:一项初步研究。
Int Wound J. 2023 Oct 27;21(2). doi: 10.1111/iwj.14460.
8
Recurrence rates in the treatment of keloids and hypertrophic scars with intralesional triamcinolone combined with other intralesional agents.曲安奈德联合其他皮损内药物治疗瘢痕疙瘩和增生性瘢痕的复发率。
Arch Dermatol Res. 2023 Dec;315(10):2757-2767. doi: 10.1007/s00403-023-02662-x. Epub 2023 Jul 11.
9
Potential genetic therapies based on m6A methylation for skin regeneration: Wound healing and scars/keloids.基于m6A甲基化的皮肤再生潜在基因疗法:伤口愈合与瘢痕/瘢痕疙瘩
Front Bioeng Biotechnol. 2023 Apr 13;11:1143866. doi: 10.3389/fbioe.2023.1143866. eCollection 2023.
10
Galunisertib Exerts Antifibrotic Effects on TGF-β-Induced Fibroproliferative Dermal Fibroblasts.加鲁钠昔特对 TGF-β 诱导的纤维增生性真皮成纤维细胞发挥抗纤维化作用。
Int J Mol Sci. 2022 Jun 15;23(12):6689. doi: 10.3390/ijms23126689.